Evidence map›Paper›PMID 23041323›Full record

ArticleGastroenterology2013

The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.

Farzad Alemi, Daniel P Poole, Jonathan Chiu, Kristina Schoonjans, Fiore Cattaruzza, John R Grider, Nigel W Bunnett, Carlos U Corvera

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06668922 (Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbiota in Patients With Irritable Bowel Syndrome), which is not on this map. Cited by 198 papers.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06668922 narecruitingnot on this mapstarted 2024, after this paper: background citation

Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbiota in Patients With Irritable Bowel Syndrome (IBS) and Control Volunteers: Diet Challenge

TypeinterventionalSponsorUniversity of California, Los AngelesRan2024 to 2030Enrolled72ConditionsIrritable Bowel Syndrome (IBS)ArmsInulin
3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 333 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Bile acid signaling in health and disease.Molecular biomedicine · 2026
    Review
  7. Article
  8. Irritable bowel syndrome.Nature reviews. Disease primers · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Nutrients · 2026
    Article
  18. GPR39-mediated molecular signaling by bile acids.The Journal of biological chemistry · 2026
    Article
  19. Review
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Farzad AlemiDepartment of Surgery, University of California, San Francisco, California, USA.
Daniel P Poole
Jonathan Chiu
Kristina Schoonjans
Fiore Cattaruzza
John R Grider
Nigel W Bunnett
Carlos U Corvera
University of California, San Francisco · USÉcole Polytechnique Fédérale de Lausanne · CHSan Francisco VA Medical Center · USUniversity of Melbourne · AUVirginia Commonwealth University Medical Center · US

Funding

ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR01DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1987 to 2019
$5.5M
REGULATION OF CELLULAR RESPONSES TO NEUROPEPTIDESR37DK039957 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2000 to 2010
$3.2M
PROTEINASE-ACTIVATED RECEPTORS/PERIPHERAL NERVOUS SYSTEMR01DK057840 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2000 to 2010
$2.2M
REGULATION OF SIGNALING BY CELL SURFACE PROTEOLYSISR01DK043207 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 1993 to 2011
$1.7M
Role of Gut Peptides in Intestinal PeristalsisR56DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 2009 to 2009
$351k
REGULATION OF SIGNALING BY CELL-SURFACE PROTEOLYSISR56DK043207 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUNNETT, NIGEL W · 2010 to 2010
$348k
ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR23DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1986 to 1986
–
REGULATION OF CELLULAR RESPONSES TO NEUROPEPTIDESR01DK039957 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BUNNETT, NIGEL W · 1987 to 1998
–
NIDDK NIH HHS DK34153NIDDK NIH HHS DK39957NIDDK NIH HHS DK43207NIDDK NIH HHS DK57840NIDDK NIH HHS R01 DK034153NIDDK NIH HHS R01 DK039957NIDDK NIH HHS R01 DK043207NIDDK NIH HHS R01 DK057840NIDDK NIH HHS R37 DK039957NIDDK NIH HHS R56 DK034153NIDDK NIH HHS R56 DK043207
6 · The paper itself

Abstract

BACKGROUND &

aimsAbnormal delivery of bile acids (BAs) to the colon as a result of disease or therapy causes constipation or diarrhea by unknown mechanisms. The G protein-coupled BA receptor TGR5 (or GPBAR1) is expressed by enteric neurons and endocrine cells, which regulate motility and secretion.

methodsWe analyzed gastrointestinal and colon transit, as well as defecation frequency and water content, in wild-type, knockout, and transgenic mice (trg5-wt, tgr5-ko, and tgr5-tg, respectively). We analyzed colon tissues for contractility, peristalsis, and transmitter release.

resultsDeoxycholic acid inhibited contractility of colonic longitudinal muscle from tgr5-wt but not tgr5-ko mice. Application of deoxycholic acid, lithocholic acid, or oleanolic acid (a selective agonist of TGR5) to the mucosa of tgr5-wt mice caused oral contraction and caudal relaxation, indicating peristalsis. BAs stimulated release of the peristaltic transmitters 5-hydroxytryptamine and calcitonin gene-related peptide; antagonists of these transmitters suppressed BA-induced peristalsis, consistent with localization of TGR5 to enterochromaffin cells and intrinsic primary afferent neurons. tgr5-ko mice did not undergo peristalsis or transmitter release in response to BAs. Mechanically induced peristalsis and transmitter release were not affected by deletion of tgr5. Whole-gut transit was 1.4-fold slower in tgr5-ko than tgr5-wt or tgr5-tg mice, whereas colonic transit was 2.2-fold faster in tgr5-tg mice. Defecation frequency was reduced 2.6-fold in tgr5-ko and increased 1.4-fold in tgr5-tg mice compared with tgr5-wt mice. Water content in stool was lower (37%) in tgr5-ko than tgr5-tg (58%) or tgr5-wt mice (62%).

conclusionsThe receptor TGR5 mediates the effects of BAs on colonic motility, and deficiency of TGR5 causes constipation in mice. These findings might mediate the long-known laxative properties of BAs, and TGR5 might be a therapeutic target for digestive diseases.

Indexed as

AnimalsCalcitonin Gene-Related PeptideColonDefecationDeoxycholic AcidEnterochromaffin CellsFecesGastrointestinal TransitIntestinal MucosaLithocholic AcidMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMuscle ContractionMuscle RelaxationCalcitonin Gene-Related PeptideDeoxycholic AcidGpbar1 protein, mouseLithocholic AcidOleanolic AcidReceptors, G-Protein-CoupledSerotoninWater

Identifiers

PMID23041323
PMCPMC6054127
OpenAlexW2003525898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.